Literature DB >> 18587683

Use of neural networks to improve quality control of interpretations in myocardial perfusion imaging.

K Tägil1, J Marving, M Lomsky, B Hesse, L Edenbrandt.   

Abstract

BACKGROUND: The aim of this study was to explore the feasibility of using a technique based on artificial neural networks for quality assurance of image reporting. The networks were used to identify potentially suboptimal or erroneous interpretations of myocardial perfusion scintigrams (MPS).
METHODS: Reversible perfusion defects (ischaemia) in each of five myocardial regions, as interpreted by one experienced nuclear medicine physician during his daily routine of clinical reporting, were assessed by artificial neural networks in 316 consecutive patients undergoing stress/rest 99mTc-sestamibi myocardial perfusion scintigraphy. After a training process, the networks were used to select the 20 cases in each region that were more likely to have a false clinical interpretation. These cases, together with 20 control cases in which the networks detected no likelihood of false clinical interpretation, were presented in random order to a group of three experienced physicians for a consensus re-interpretation; no information regarding clinical or neural network interpretations was provided to the re-evaluation panel.
RESULTS: The clinical interpretation and the re-evaluation differed in 53 of the 200 cases. Forty-six of the 53 cases (87%) came from the group selected by the neural networks, and only seven (13%) were control cases (P < 0.001). The disagreements between clinical routine interpretation by an experienced nuclear medicine expert and artificial networks were related to small and mild perfusion defects and localization of defects.
CONCLUSION: The results demonstrate that artificial neural networks can identify those myocardial perfusion scintigrams that may have suboptimal image interpretations. This is a potentially highly cost-effective technique, which could be of great value, both in daily practice as a clinical decision support tool and as a tool in quality assurance.

Entities:  

Mesh:

Year:  2008        PMID: 18587683     DOI: 10.1007/s10554-008-9329-x

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  12 in total

Review 1.  ACCF/ASNC appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI): a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group and the American Society of Nuclear Cardiology endorsed by the American Heart Association.

Authors:  Ralph G Brindis; Pamela S Douglas; Robert C Hendel; Eric D Peterson; Michael J Wolk; Joseph M Allen; Manesh R Patel; Ira E Raskin; Robert C Hendel; Timothy M Bateman; Manuel D Cerqueira; Raymond J Gibbons; Linda D Gillam; John A Gillespie; Robert C Hendel; Ami E Iskandrian; Scott D Jerome; Harlan M Krumholz; Joseph V Messer; John A Spertus; Stephen A Stowers
Journal:  J Am Coll Cardiol       Date:  2005-10-18       Impact factor: 24.094

2.  ACCF proposed method for evaluating the appropriateness of cardiovascular imaging.

Authors:  Manesh R Patel; John A Spertus; Ralph G Brindis; Robert C Hendel; Pamela S Douglas; Eric D Peterson; Michael J Wolk; Joseph M Allen; Ira E Raskin
Journal:  J Am Coll Cardiol       Date:  2005-10-18       Impact factor: 24.094

3.  Myocardial perfusion scintigraphy in the UK: insights from the British Nuclear Cardiology Society Survey 2000.

Authors:  A D Kelion; C Anagnostopoulos; M Harbinson; S R Underwood; M Metcalfe
Journal:  Heart       Date:  2005-09       Impact factor: 5.994

Review 4.  The new era of medical imaging--progress and pitfalls.

Authors:  John K Iglehart
Journal:  N Engl J Med       Date:  2006-06-29       Impact factor: 91.245

5.  Validation of a new automated method for analysis of gated-SPECT images.

Authors:  Milan Lomsky; Jens Richter; Lena Johansson; Poul F Høilund-Carlsen; Lars Edenbrandt
Journal:  Clin Physiol Funct Imaging       Date:  2006-05       Impact factor: 2.273

6.  Improved classifications of myocardial bull's-eye scintigrams with computer-based decision support system.

Authors:  D Lindahl; J Lanke; A Lundin; J Palmer; L Edenbrandt
Journal:  J Nucl Med       Date:  1999-01       Impact factor: 10.057

Review 7.  The use of computer-assisted diagnosis in cardiac perfusion nuclear medicine studies: a review (Part 3)

Authors:  F L Datz; C Rosenberg; F V Gabor; P E Christian; G T Gullberg; R Ahluwalia; K A Morton
Journal:  J Digit Imaging       Date:  1993-05       Impact factor: 4.056

8.  Interobserver variability in the detection of cervical-thoracic Hodgkin's disease by computed tomography.

Authors:  B D Fletcher; A S Glicksman; P Gieser
Journal:  J Clin Oncol       Date:  1999-07       Impact factor: 44.544

9.  Diagnostic performance of an expert system for the interpretation of myocardial perfusion SPECT studies.

Authors:  E V Garcia; C D Cooke; R D Folks; C A Santana; E G Krawczynska; L De Braal; N F Ezquerra
Journal:  J Nucl Med       Date:  2001-08       Impact factor: 10.057

10.  A new automated method for analysis of gated-SPECT images based on a three-dimensional heart shaped model.

Authors:  Milan Lomsky; Jens Richter; Lena Johansson; Henrik El-Ali; Karl Aström; Michael Ljungberg; Lars Edenbrandt
Journal:  Clin Physiol Funct Imaging       Date:  2005-07       Impact factor: 2.273

View more
  2 in total

1.  Usefulness of an artificial neural network for a beginner to achieve similar interpretations to an expert when examining myocardial perfusion images.

Authors:  A Chiba; T Kudo; R Ideguchi; M Altay; S Koga; T Yonekura; A Tsuneto; M Morikawa; S Ikeda; H Kawano; Y Koide; M Uetani; K Maemura
Journal:  Int J Cardiovasc Imaging       Date:  2021-03-11       Impact factor: 2.357

2.  Deep learning applications in myocardial perfusion imaging, a systematic review and meta-analysis.

Authors:  Ebraham Alskaf; Utkarsh Dutta; Cian M Scannell; Amedeo Chiribiri
Journal:  Inform Med Unlocked       Date:  2022
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.